International Congress on Oncology Research and Development (iCORD), October 05-06, 2019, Taj Palace, New Delhi
The International Congress on Oncology Research and Development (iCORD), will be held at Taj Palace, New Delhi, from October 05-06, 2019.
iCORD is an initiative to bring all stakeholders involved in cancer research and patient care to a common platform discuss and advocate the latest developments in oncology research, drugs/diagnostics, technology, therapies, and patient care programs. It’s an international annual event with aims to promote best in the class, high standard of care in line with global healthcare standards to cancer patients in India.
There are 30+ invited speakers in congress from India and abroad. The congress speakers include research experts from Industry, Patient Advocacy Groups and Practicing Oncologist across specialties from India and abroad. The conference agenda can be downloaded from https://goicord.com/agenda/.
Conference registrations are open and delegates can enjoy early birds rates until July 15 2019.
The congress will be attended by KOLs across oncology specialties (medical, radiation, surgical, pediatric), Hospitals, Academia, Industry professionals (pharmaceutical, medical biotechnology , medical device, medical imaging solution providers, CROs, SMOs, KPOs, clinical trial supplies storage and logistics providers, market research companies, molecular and central labs, diagnostic and radiological service providers, translation service providers, clinical trials and oncology research software/services providers), medical graduates, and patient advocacy and support groups. Its an excellent platform for clinical research companies to meet the KOLs involved in global oncology clinical trials and to discuss the feasibility of upcoming clinical trials.
The congress also feature an exhibition showcasing thenew biotech companies with clinical trials pipelines, clinical research centers/CROs/SMOs/central labs/image reading centers, electronic/software solutions providers engaged in oncology clinical trials, pharma/medical device companies, medical technology service providers, diagnostic imaging agents and radiopharmaceuticals companies with oncology portfolios and wellness solutions/products providers among other exhibitors.
iCORD vision is to translate all oncology research towards cancer patient care. The involvement and support of all stakeholders engaged in cancer patients treatment, support, product/services, research, and advocacy are welcome to support this initiative.
For more details on the iCORD, please visit www.goicord.com.
